Sort by
Medicine and Dentistry
Randomized Controlled Trial
100%
Mesenchymal Stem Cell
100%
Adjuvant Therapy
100%
Umbilical Cord
100%
COVID-19
100%
Survival Rate
44%
Adverse Event
22%
Table Salt
22%
Patient Referral
11%
Intensive Care Unit
11%
Body Weight
11%
Infusion
11%
Interleukin 6
11%
Antiinflammatory Agent
11%
Anti-Inflammatory Drug
11%
Acute Respiratory Distress Syndrome
11%
T Helper 2 Cell
11%
Cytokine Storm
11%
Intravenous Drug Administration
11%
Immune System
11%
Comorbidity
11%
Keyphrases
Randomized Controlled Trial
100%
Adjuvant Therapy
100%
Human Umbilical Cord Mesenchymal Stromal Cells
100%
COVID-19
100%
Survival Rate
44%
Critically Ill Patients
33%
Indonesia
11%
Jakarta
11%
Intensive Care Unit
11%
Referral Hospital
11%
Immune System
11%
Serious Adverse Events
11%
Adverse Events
11%
Length of Stay
11%
Comorbidity
11%
Interleukin-6
11%
Multi-centered
11%
Clinical Improvement
11%
T Helper 2
11%
Anti-inflammatory Agents
11%
Acute Respiratory Distress Syndrome
11%
Ventilator
11%
Intensive Care Ventilator
11%
Cytokine Storm
11%
Inflammatory State
11%
Intravenous Infusion
11%
0.9% Saline
11%
Laboratory Improvement
11%
Recovered Patients
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Coronavirinae
100%
Adjuvant
100%
Diseases
100%
Survival Rate
66%
Adverse Event
33%
Table Salt
33%
Anti-Inflammatory Drug
16%
Interleukin 6
16%
Antiinflammatory Agent
16%
Adult Respiratory Distress Syndrome
16%
Cytokine Storm
16%
Comorbidity
16%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Umbilical Cord
100%
COVID-19
100%
Adjuvant
100%
Survival Rate
44%
Solution and Solubility
22%
Interleukin 6
11%
Body Weight
11%
T Helper 2 Cell
11%
Cytokine Storm
11%
Comorbidity
11%
Immune System
11%
Nursing and Health Professions
Adjuvant Therapy
100%
Diseases
100%
Survival Rate
66%
Adverse Event
33%
Table Salt
33%
Patient Referral
16%
Intensive Care Unit
16%
Body Weight
16%
Antiinflammatory Agent
16%
Length of Stay
16%
Interleukin 6
16%
Adult Respiratory Distress Syndrome
16%
Infusion
16%
Intravenous Drug Administration
16%
Cytokine Storm
16%
Comorbidity
16%